Long-term survival of a patient with prosthetic valve endocarditis due to Trichosporon beigelii

Eur J Clin Microbiol Infect Dis. 1991 Sep;10(9):756-8. doi: 10.1007/BF01972504.

Abstract

A case is described of a 49-year-old man with rheumatic aortic valve disease who developed endocarditis seven years after valvular replacement. Trichosporon beigelii was isolated from the blood, a peripheral thrombus, and the removed prosthesis. After two valve prosthesis replacements and prolonged antifungal therapy, the patient survived for four years, but eventually died as a consequence of multiple septic complications due to the same organism. To the authors' knowledge, this is the longest survival time of any reported case of Trichosporon prosthetic valve endocarditis.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use
  • Endocarditis / drug therapy
  • Endocarditis / microbiology*
  • Fluconazole / therapeutic use
  • Heart Valve Prosthesis / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Mycoses / drug therapy
  • Mycoses / microbiology*
  • Prognosis
  • Prosthesis-Related Infections / drug therapy
  • Prosthesis-Related Infections / microbiology*
  • Spain / epidemiology
  • Time Factors
  • Trichosporon / isolation & purification*

Substances

  • Amphotericin B
  • Fluconazole